LETKO, BROSSEAU & ASSOCIATES INC - HERON THERAPEUTICS INC ownership

HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 182 filers reported holding HERON THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 2.03 and the average weighting 0.3%.

Quarter-by-quarter ownership
LETKO, BROSSEAU & ASSOCIATES INC ownership history of HERON THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$241,000
+50.6%
57,2000.0%0.01%
+66.7%
Q2 2022$160,000
-51.1%
57,2000.0%0.00%
-40.0%
Q1 2022$327,000
-37.4%
57,2000.0%0.01%
-28.6%
Q4 2021$522,000
-14.6%
57,2000.0%0.01%
-22.2%
Q3 2021$611,000
-31.2%
57,2000.0%0.01%
-25.0%
Q2 2021$888,000
-4.2%
57,2000.0%0.01%
-7.7%
Q1 2021$927,000
-23.5%
57,2000.0%0.01%
-23.5%
Q4 2020$1,211,000
+42.8%
57,2000.0%0.02%
+30.8%
Q3 2020$848,000
+28.1%
57,200
+27.1%
0.01%
+30.0%
Q2 2020$662,00045,0000.01%
Other shareholders
HERON THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
TANG KEVIN C 760$1,900100.00%
Velan Capital Investment Management LP 2,500,000$6,250,0005.52%
GREAT POINT PARTNERS LLC 6,360,161$15,900,4033.12%
Cheyne Capital Management (UK) LLP 318,008$795,0201.39%
TANG CAPITAL MANAGEMENT LLC 3,755,934$9,389,8351.36%
Rubric Capital Management LP 11,750,000$29,375,0001.28%
Orchard Capital Management, LLC 1,391,080$3,477,7001.17%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 267,028$667,5700.81%
CM Management, LLC 250,000$6250.75%
Tejara Capital Ltd 493,619$1,234,0480.71%
View complete list of HERON THERAPEUTICS INC shareholders